Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ORION: Optimization of Reperfusion to Improve Outcome and Neurological Function in Late-Window Acute Ischemic Stroke
CTR20250984Phase 3Active
- Sponsor
- CORXEL Pharmaceuticals
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of JX10 in ischemic stroke, sponsored by CORXEL Pharmaceuticals. Started May 2025; status: active.
02
Drugs
JX10
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on CTR20250984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250984.